PEAK PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
PEAK PHARMACEUTICALS, INC. (RMHI) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$2.34 million for the 12-month period ending 2015-09-30, per its 10-K filed 2016-01-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2016-01-13
- PEAK PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was -$2.34M.
- PEAK PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was -$3.76M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2015-09-30 | -$2.34M 10-K · filed 2016-01-13 |
| 2014-09-30 | -$3.76M 10-K · filed 2016-01-13 |